FDA Investigator Ankur C Patel

Ankur C Patel has conducted inspections on 24 sites in 3 countries as of 14 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
24
Last Inspection Date:
14 May 2024
Investigator Role:
FDA Investigator
Redica ID:
100001136
Countries of Inspections:
United States of America, Japan, India
FDA Investigators that have inspected at least one site in common with Ankur C Patel:
Addam S Reynolds, Adetutu M Gidado, Alan P Kurtzberg, Alice S Tsao, Amy L Singer, Amy M Cramer, Annemarie Bodnar, Anthony J Donato, Asia D Clark, Atul J Agrawal, Barbara Jwilimczyk Macri, Bijoy Panicker, Carl Lee, Christina K Theodorou, Christine M Cerenzio, Craig D Zagata, Daniel J Grabicki, Daniel J Min, David A Oluwo, Dawn L Wydner, Deborah J Parris, Denise M Digiulio, Devaughn Edwards, Devon Jenkins, Douglas C Kovacs, Elaine E Gilfillan, Emest F Bizjak, Emmanuel Jramos Maldonado, Eric Rothschild, Erika V Butler, Erin D Mccaffery, Frank J Marciniak, Frederick F Razzaghi, Gabrielle J Swain, George Pyramides, Guerlain Ulysse, Helen B Ricalde, Helen Verdel, James M Mason, James Norman, James R Birkenstamm, Janet A Rajan, Jessica S Estriplet, Jogy George, John D Mcintosh, Jose M Cayuela, Josh Renzo N Ramilo, Joy Rkozlowski Klena, Karen E D'orazio, Karen F Tomaziefski, Karishma G Gopaul, Keith M Reilly, Kelli F Dobilas, Kelli Regente, Ko U Min, Kristina J Donohue, Kristy A Zielny, Lata C Mathew, PhD, Lauren L Vajo, Lawrence Harmon, Jr, LCDR Susan E Polifko, Li Li, Liatte Kreuger, PharmD, Lillie D Witcher, Lisa M Bellows, Loretta Nemchik, Marcellinus D Dordunoo, Marea K Harmon, Margaret M Sands, Maria Estrella, Melissa T Roy, Michael L Casner, Michael R Klapal, Michael Serrano, Monika Borkowska, Nancy F Scheraga, Nancy M Espinal, Nayan J Patel, Nerizza B Guerin, Nicholas A Violand, Niketa Patel, Nina Yang, Odera I Ekwunife, Paul E Stein, Paul L Bellamy, Pratik S Upadhyay, DDC, Puspa Suresh Jayasekara, Rachel C Harrington, Reba A Gates, Regina T Brown, Robert D Tollefsen, Robin P Mathew, Rose Ljean Mary, Rose Xu, Rumany C Penn, PharmD, Russell J Glapion, Sachinkumar V Patel, Saied A Asbagh, Saleem A Akhtar, Samina S Khan, Sarah Forney, Satheesh Thomas, Sayyem H Akbar, Simone E Pitts, Sinai I Davis, Sixto M Mercado Rios, Sony Mathews, Stephen J Koniers, Stephen J Mottola, Stephenie M Ortiz, Susan M Halsted, Syeda N Mahazabin, Tamil Arasu, PhD, Tanya R Syffrard, Tara G Bizjak, Tara R Gooen, Tarun D Mehta, Thomas E Friel, Tiffani D Wilson, Tyanna N Hadley, Unnee Ranjan, Xiaohan Cai, PhD, Ying Zhang, Yvesna C Blaise, Yvins Dezan, Zakaria I Ganiyu

Ankur C Patel's Documents

Publish Date Document Type Title
May, 2023 FDA 483 Chartwell Pharmaceuticals Congers, LLC. - Form 483, 2023-05-24
March, 2023 FDA 483 Cetylite Industries, Inc. - Form 483, 2023-03-02
March, 2023 FDA 483 Response Cetylite Industries, Inc. - Form 483R, 2023-03-02
July, 2021 FDA 483 Response SPECTRUM LABORATORY PRODUCTS INC. dba SPECTRUM CHEMICAL MFG. CORP. - Form 483R, 2021-07-14
July, 2021 EIR SPECTRUM LABORATORY PRODUCTS INC. dba SPECTRUM CHEMICAL MFG. CORP. - EIR, 2021-07-14
May, 2021 FDA 483 CMIC CMO USA CORP - Form 483, 2021-05-04
September, 2021 FDA 483 Paramesh Banerji Life Sciences LLC - Form 483, 2021-09-24
May, 2021 EIR CMIC CMO USA CORP - EIR, 2021-05-04
July, 2021 FDA 483 SPECTRUM LABORATORY PRODUCTS INC. dba SPECTRUM CHEMICAL MFG. CORP. - Form 483, 2021-07-19
August, 2023 FDA 483 APPCO PHARMA LLC - Form 483, 2023-08-29
May, 2022 FDA 483 Vantage Specialty Ingredients, Inc - Form 483, 2022-05-02
June, 2022 FDA 483 ARx, LLC - Form 483, 2022-06-03
March, 2022 FDA 483 SAMJAN GROUP INC. (DBA PLS Analytical) - Form 483, 2022-03-03
August, 2022 FDA 483 Linde Gas & Equipment Inc. - Form 483, 2022-08-11
October, 2023 FDA 483 Eisai Co., Ltd. - Form 483, 2023-10-27

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more